Company: CERO
Filing Date: 2025-05-27
Form Type: POS AM
Source: 0001213900-25-047469
Chunk: 395

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-05-27
Form: POS AM
Chunk 395
---
 form of tax credit carryforwards, which would attract a full valuation allowance. There are no provisions for which it
is reasonably possible that the total amounts of unrecognized tax benefits will significantly increase or decrease within 12 months of
the reporting date. Because the statute of limitations does not expire until after the net operating loss and credit carryforwards are
actually used, the statutes are still open on calendar years ended 2016 and 2017 forward for federal and state purposes.

The Company did not recognize
any expense for interest and penalties related to uncertain tax positions during 2024 and 2023, and the Company does not have any amounts
related to interest and penalties accrued as of December 31, 2024 and 2023.

The Company files U.S. federal
and state tax returns. The Company’s tax years will remain open for examination by the federal and state authorities for three and
four years, respectively, from the date of utilization of any net operating loss credit.

A reconciliation of the beginning
and ending amount of the liability for uncertain tax positions, excluding potential interest and penalties, is as follows:

| Balance as of December 31, 2023                         |     | $ | 459,000 |
| Increase/(decrease) based on current year tax positions |     |   |  79,000 |
| Increase/(decrease) for prior year tax positions        |     |   |       - |
| Lapses of applicable statutes                           |     |   |       - |
| Balance as of December 31, 2024                         |     | $ | 538,000 |

NOTE 13 – 401(k) RETIREMENT SAVINGS PLAN The Company sponsors a 401(k) defined contribution plan covering eligible employees who elect to participate. The Company is allowed to make discretionary profit sharing and 401(k) matching contributions as defined in the plan and as approved by the Board of Directors. The Company’s contributions for the period from February 14, 2024 through December 31, 2024 was $ 44,077and Predecessor contributions during the period from January 1, 2024 through February 13, 2024 was $ 8,657. The Predecessor made contributions of $ 63,344during the year ended December 31, 2023. F-60

NOTE 14 – RELATED-PARTY TRANSACTIONS

In February 2024, we issued
and sold an aggregate of shares of Series